Eugenol enhancement of transdermal drug delivery

Details Eugenol enhancement of transdermal drug delivery Eugenol enhancement of transdermal drug delivery

1987-01-16

1989-12-19

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514946, 514947, A61K 31045

Patent

active

048883620

ABSTRACT:
Disclosed herein are compositions and methods for enhancing the transdermal delivery of physiologically active agents across mammalian skin or membranes and which comprise a percutaneous transfer enhancing amount of eugenol and a drug.

REFERENCES:
patent: 3551554 (1970-12-01), Herchler
patent: 3896238 (1975-07-01), Smith
patent: 3952099 (1976-04-01), Smith
patent: 3989816 (1976-11-01), Radjadhyaksha
patent: 4046886 (1977-09-01), Smith
patent: 4316893 (1976-11-01), Rajadhyaksha
patent: 4405616 (1983-09-01), Rajadhyaksha
Chem. Abst. 90 (1979-43846f).

Affiliated with

Also associated with

Rating

Eugenol enhancement of transdermal drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Eugenol enhancement of transdermal drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eugenol enhancement of transdermal drug delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1903227